Bone markers in multiple myeloma

This publication has 95 references indexed in Scilit:

• Predictive Value of Bone Resorption and Formation Markers in Cancer Patients With Bone Metastases Receiving the Bisphosphonate Zoledronic Acid
  Journal of Clinical Oncology, 2005
• Proteasome inhibitors abrogate osteoclast differentiation and osteoclast function
  Biochemical and Biophysical Research Communications, 2005
• Expression of receptor activator of NF-?B ligand (RANKL) mRNA in human multiple myeloma cells
  Zeitschrift für Krebsforschung und Klinische Onkologie, 2004
• Myeloma cells can directly contribute to the pool of RANKL in bone bypassing the classic stromal and osteoblast pathway of osteoclast stimulation
  British Journal of Haematology, 2004
• Stromal Cell-Derived Factor-1 (SDF-1) Recruits Osteoclast Precursors by Inducing Chemotaxis, Matrix Metalloproteinase-9 (MMP-9) Activity, and Collagen Transmigration
  Journal of Bone and Mineral Research, 2003
• Tartrate‐resistant acid phosphatase isoform 5b: A novel serum marker for monitoring bone disease in multiple myeloma
  International Journal of Cancer, 2003
• Protein Expression and Functional Difference of Membrane-Bound and Soluble Receptor Activator of NF-κB Ligand: Modulation of the Expression by Osteotropic Factors and Cytokines
  Biochemical and Biophysical Research Communications, 2000
• Cancer Cells Responsible for Humoral Hypercalcemia Express mRNA Encoding a Secreted Form of ODF/TRANCE That Induces Osteoclast Formation
  Biochemical and Biophysical Research Communications, 2000
• Osteoprotegerin Production by Human Osteoblast Lineage Cells Is Stimulated by Vitamin D, Bone Morphogenetic Protein-2, and Cytokines
  Biochemical and Biophysical Research Communications, 1998
• Production of Lymphotoxin, a Bone-Resorbing Cytokine, by Cultured Human Myeloma Cells
  New England Journal of Medicine, 1987